|
|
|
|
|
|
|
30.03.26 - 14:06
|
Neogen to Release Third-Quarter Fiscal Year 2026 Financial Results on April 9, 2026 (Business Wire)
|
|
|
LANSING, Mich.--(BUSINESS WIRE)--Neogen® Corporation (NASDAQ: NEOG) will issue its third-quarter earnings release before the opening of the market on Thursday, April 9, 2026. Executives from the company will host a webcast and conference call later that morning, beginning at 8:00 a.m. Eastern time. During the call, Neogen management will provide a financial overview and business update of the company's performance for the third-quarter of fiscal year 2026.
The conference call can be accessed by dialing:
Toll-Free - North America: (1) 888-660-6264
International: (+1) 646-517-3975
Conference ID: 70064#
The live webcast can be accessed through Neogen's Investor Relations webpage, neogen.com/investor-relations, under the “Events & Presentations” subheading.
A replay of the conference call and webcast will be available shortly following the conclusion of the call and can be accessed by dialing:
Toll-Free - North America: (1) 877-674-7070
International: (+1) 416-764-8692
Passcode: 70064 #
It will also be...
|
|
|
27.03.26 - 12:03
|
/R E P E A T -- NEOGEN TEAMSTERS TO RALLY FOR FIRST CONTRACT (PR Newswire)
|
|
|
Local 243 Warehouse Workers Demand Fair Agreement LANSING, Mich., March 27, 2026 /PRNewswire/ -- Warehouse workers at Neogen in Lansing, Mich., represented by Teamsters Local 243, will hold a rally at 10 a.m. on Friday, March 27, to demand a fair first contract. The company has committed......
|
|
|
26.03.26 - 20:03
|
NEOGEN TEAMSTERS TO RALLY FOR FIRST CONTRACT (PR Newswire)
|
|
|
Local 243 Warehouse Workers Demand Fair Agreement LANSING, Mich., March 26, 2026 /PRNewswire/ -- Warehouse workers at Neogen in Lansing, Mich., represented by Teamsters Local 243, will hold a rally at 10 a.m. on Friday, March 27, to demand a fair first contract. The company has committed......
|
|
|
02.03.26 - 13:06
|
Zoetis to Acquire Animal Genomics Business from Neogen®, Accelerating Precision Animal Health Innovation (Business Wire)
|
|
|
Acquisition strengthens Zoetis' leadership in Precision Animal Health by integrating Neogen's global genomics capabilities, expanding predictive insights and individualized care worldwidePARSIPPANY, N.J.--(BUSINESS WIRE)--$ZTS #animalhealth--Zoetis Inc. (NYSE: ZTS) the world's leading animal health company, today announced it has entered into a definitive agreement with Neogen Corporation (NASDAQ: NEOG) (“Neogen”) to acquire Neogen's animal genomics business for $160 million, subject to customary closing adjustments. This acquisition aligns directly with Zoetis' strategy to drive future livestock innovation through genomics, reinforcing its commitment to livestock producers worldwide and advancing its Precision Animal Health portfolio. By integrating Neogen's genomic technologies and data solutions, Zoetis is expanding its capabilities to deliver predictive insights, individualized care, and greater value to customers across major livestock and companion animal species.
Neogen's genomics busine...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
08.01.26 - 13:03
|
Neogen Announces Second-Quarter 2026 Results (Business Wire)
|
|
|
Revenue of $224.7 million, a decrease of 2.8% YoY; Core growth1 increased 2.9% YoY
Net loss of $15.9 million; Adjusted Net Income1 of $22.6 million
Adjusted EBITDA1 of $48.7 million; Adjusted EBITDA margin1 increased 470 bps sequentially
Company hires key senior commercial leaders
Petrifilm manufacturing transition remains on track
Raising FY 2026 revenue and Adjusted EBITDA guidance
1 Non-GAAP financial measures; see explanations and reconciliations that followLANSING, Mich.--(BUSINESS WIRE)--Neogen Corporation (NASDAQ: NEOG) announced today the results of the second quarter ended November 30, 2025.
“I am exceptionally proud of the Neogen team as we have initiated the first phase of our strategic transformation with early work focused on stabilizing and strengthening our core business. While it is early in the process, and our industry is currently seeing macro headwinds, our team drove significant sequential improvement in core revenue growth and profitability in the second quarter,” said Mike Nassi...
|
|